Cargando…
Mapping of m(6)A and Its Regulatory Targets in Prostate Cancer Reveals a METTL3-Low Induction of Therapy Resistance
Recent evidence has highlighted the role of N(6)-methyladenosine (m(6)A) in the regulation of mRNA expression, stability, and translation, supporting a potential role for posttranscriptional regulation mediated by m(6)A in cancer. Here, we explore prostate cancer as an exemplar and demonstrate that...
Autores principales: | Cotter, Kellie A., Gallon, John, Uebersax, Nadine, Rubin, Philip, Meyer, Kate D., Piscuoglio, Salvatore, Jaffrey, Samie R., Rubin, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349875/ https://www.ncbi.nlm.nih.gov/pubmed/34088870 http://dx.doi.org/10.1158/1541-7786.MCR-21-0014 |
Ejemplares similares
-
Alternative splicing of METTL3 explains apparently METTL3-independent m(6)A modifications in mRNA
por: Poh, Hui Xian, et al.
Publicado: (2022) -
The evolving landscape of prostate cancer somatic mutations
por: Cotter, Kellie, et al.
Publicado: (2022) -
N
(6)-methyladenosine modification and METTL3 modulate enterovirus 71 replication
por: Hao, Haojie, et al.
Publicado: (2019) -
Large-scale mapping of sequence-function relations in small regulatory RNAs reveals plasticity and modularity
por: Peterman, Neil, et al.
Publicado: (2014) -
SUMOylation of the m(6)A-RNA methyltransferase METTL3 modulates its function
por: Du, Yuzhang, et al.
Publicado: (2018)